Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Foà

Showing results (41-50 of 529) with videos related to

Pageof 53
Sort By:
Leukemia & Lymphoma|July 22, 2011
Chronic lymphocytic leukemia in less fit patients: "slow-go"Ilaria Del Giudice, Francesca Romana Mauro, Robin Foà
Hematology (Amsterdam, Netherlands)|September 29, 2005
A broad and integrated diagnostic work-up for a modern management of Acute Lymphoblastic Leukemia (ALL)Robin Foà, Antonella Vitale, Sabina Chiaretti, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|June 28, 2014
Genomic characterization of acute leukemiasSabina Chiaretti, Valentina Gianfelici, Giulia Ceglie, et al.
Pediatric Reports|November 5, 2011
Myeloid/T-cell acute lymphoblastic leukemia in children and adultsSabina Chiaretti, Monica Messina, Simona Tavolaro, et al.
Hematology. American Society of Hematology. Education Program|December 10, 2021
Does MRD have a role in the management of iNHL?Ilaria Del Giudice, Irene Della Starza, Robin Foà
Current Opinion in Oncology|October 15, 2005
New developments in the diagnosis, prognosis and treatment of chronic lymphocytic leukemiaMassimo Gentile, Francesca Romana Mauro, Anna Guarini, et al.
Immunotherapy|March 15, 2016
The antileukemic potential of natural killer cellsGiovanni F Torelli, Nadia Peragine, Paola Mariglia, et al.
Haematologica|February 5, 2008
Childhood polycythemia vera and essential thrombocythemia: does their pathogenesis overlap with that of adult patients?Luciana Teofili, Robin Foà, Fiorina Giona, et al.
Therapeutic Advances in Hematology|March 12, 2019
Insights into the optimal use of ponatinib in patients with chronic phase chronic myeloid leukaemiaMatteo Molica, Emilia Scalzulli, Gioia Colafigli, et al.
Scientific Reports|January 19, 2024
PSGL-1 decorated with sialyl Lewis<sup>a/x</sup> promotes high affinity binding of myeloma cells to P-selectin but is dispensable for E-selectin engagementMichael O'Dwyer, Lucy Kirkham-McCarthy, Marina Cerreto, et al.
Pageof 53

Showing results (41-50 of 529) with videos related to

Sort By:
Pageof 53
Leukemia & Lymphoma|July 22, 2011
Chronic lymphocytic leukemia in less fit patients: "slow-go"Ilaria Del Giudice, Francesca Romana Mauro, Robin Foà
Hematology (Amsterdam, Netherlands)|September 29, 2005
A broad and integrated diagnostic work-up for a modern management of Acute Lymphoblastic Leukemia (ALL)Robin Foà, Antonella Vitale, Sabina Chiaretti, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|June 28, 2014
Genomic characterization of acute leukemiasSabina Chiaretti, Valentina Gianfelici, Giulia Ceglie, et al.
Pediatric Reports|November 5, 2011
Myeloid/T-cell acute lymphoblastic leukemia in children and adultsSabina Chiaretti, Monica Messina, Simona Tavolaro, et al.
Hematology. American Society of Hematology. Education Program|December 10, 2021
Does MRD have a role in the management of iNHL?Ilaria Del Giudice, Irene Della Starza, Robin Foà
Current Opinion in Oncology|October 15, 2005
New developments in the diagnosis, prognosis and treatment of chronic lymphocytic leukemiaMassimo Gentile, Francesca Romana Mauro, Anna Guarini, et al.
Immunotherapy|March 15, 2016
The antileukemic potential of natural killer cellsGiovanni F Torelli, Nadia Peragine, Paola Mariglia, et al.
Haematologica|February 5, 2008
Childhood polycythemia vera and essential thrombocythemia: does their pathogenesis overlap with that of adult patients?Luciana Teofili, Robin Foà, Fiorina Giona, et al.
Therapeutic Advances in Hematology|March 12, 2019
Insights into the optimal use of ponatinib in patients with chronic phase chronic myeloid leukaemiaMatteo Molica, Emilia Scalzulli, Gioia Colafigli, et al.
Scientific Reports|January 19, 2024
PSGL-1 decorated with sialyl Lewis<sup>a/x</sup> promotes high affinity binding of myeloma cells to P-selectin but is dispensable for E-selectin engagementMichael O'Dwyer, Lucy Kirkham-McCarthy, Marina Cerreto, et al.
Pageof 53